Aimmune Therapeutics is based in Brisbane. It has raised $2.6B in total funding. Backed by Nestlé.
Aimmune Therapeutics funding overview
Aimmune Therapeutics is based in Brisbane. Aimmune Therapeutics has raised $2.6B in total disclosed funding. That places its disclosed total in over $1B. The round record for Aimmune Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Nestlé.
Aimmune Therapeutics at a glance
Total raised
$2.6B
Latest round date
August 2020
Headquarters
Brisbane
Notable investors
Nestlé
Frequently asked about Aimmune Therapeutics funding
How much has Aimmune Therapeutics raised?
Aimmune Therapeutics has raised $2.6B in total disclosed funding across the rounds on record.
Who has invested in Aimmune Therapeutics?
Nestlé are named among the investors backing Aimmune Therapeutics.
What was the latest Aimmune Therapeutics funding round?
No round stage has been disclosed for Aimmune Therapeutics.
Where is Aimmune Therapeutics based?
Aimmune Therapeutics is based in Brisbane.
When did Aimmune Therapeutics last raise?
The last disclosed Aimmune Therapeutics round closed in August 2020.
We update the Aimmune Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Brisbane and their backers are listed below.
